Laboratory for Medicinal Chemistry (Campus Heymans), Ghent University, Ottergemsesteenweg 460, B-9000, Gent, Belgium.
Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Universiteitsplein 1 (S7), B-2610, Wilrijk, Belgium.
Eur J Med Chem. 2021 Feb 15;212:113101. doi: 10.1016/j.ejmech.2020.113101. Epub 2020 Dec 29.
The kinetoplastid parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. are the causative agents of neglected tropical diseases with a serious burden in several parts of the world. These parasites are incapable of synthesizing purines de novo, and therefore rely on ingenious purine salvage pathways to acquire and process purines from their host. Purine nucleoside analogs that may interfere with these pathways therefore constitute a privileged source of new antikinetoplastid agents. In this study, we synthetized a collection of C-nucleosides employing five different heterocyclic nucleobase surrogates. C-nucleosides are chemically and enzymatically stable and allow for extensive structural modification. Inspired by earlier 7-deazaadenosine nucleosides and known antileishmanial C-nucleosides, we introduced different modifications tailored towards antikinetoplastid activity. Both adenosine and inosine analogs were synthesized with the aim of discovering new antikinetoplastid hits and expanding knowledge of structure-activity relationships. Several promising hits with potent activity against Trypanosoma brucei, Trypanosoma cruzi and Leishmania infantum were discovered, and the nature of the nucleobase surrogate was found to have a profound influence on the selectivity profile of the compounds.
动基体原虫寄生虫(锥虫、克氏锥虫和利什曼原虫等)是被忽视热带病的病原体,在世界上许多地方都造成了严重的负担。这些寄生虫不能从头合成嘌呤,因此依赖巧妙的嘌呤补救途径从宿主中获取和处理嘌呤。可能干扰这些途径的嘌呤核苷类似物因此构成了新型抗动基体原虫药物的主要来源。在这项研究中,我们使用了五种不同的杂环核苷碱基替代物合成了一系列 C-核苷。C-核苷在化学和酶学上都很稳定,并且允许进行广泛的结构修饰。受早期 7-脱氮腺苷核苷和已知的抗利什曼原虫 C-核苷的启发,我们引入了针对抗动基体原虫活性的不同修饰。合成了腺苷和肌苷类似物,旨在发现新的抗动基体原虫化合物并扩展结构-活性关系的知识。发现了一些具有针对布鲁氏锥虫、克氏锥虫和婴儿利什曼原虫的强活性的有希望的化合物,并且发现核苷碱基替代物的性质对化合物的选择性有深远的影响。